Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.010 Biomarker disease BEFREE A statistically significant difference was found between the pterygium and control groups for the ACE I/D polymorphism (p<0.001). 25341451 2014
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.010 AlteredExpression disease BEFREE Expression of mTOR in Primary Pterygium and its Correlation with α-Smooth Muscle Actin. 28623647 2017
Entrez Id: 10598
Gene Symbol: AHSA1
AHSA1
0.010 Biomarker disease BEFREE Rosiglitazone suppresses TGF-β1-induced myofibroblast activation and extra cellular matrix synthesis in pterygium fibroblasts at least partly through the modulation of the p38 MAPK pathway. 29049722 2017
Entrez Id: 7965
Gene Symbol: AIMP2
AIMP2
0.010 Biomarker disease BEFREE Rosiglitazone suppresses TGF-β1-induced myofibroblast activation and extra cellular matrix synthesis in pterygium fibroblasts at least partly through the modulation of the p38 MAPK pathway. 29049722 2017
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.010 Biomarker disease BEFREE The results also suggested the potential of miR-21 and the PTEN/AKT pathway as a novel therapeutic strategy for pterygium. 30967746 2018
Entrez Id: 218
Gene Symbol: ALDH3A1
ALDH3A1
0.010 AlteredExpression disease BEFREE Among these genes, we chose three proteins, aldehyde dehydrogenase, dimeric NADP-preferring (ALDH3A1), protein disulfide-isomerase A3 (PDIA3), and peroxiredoxin-2 (PRDX2), that were significantly upregulated in pterygium and further increased in recurrent pterygium. 25221425 2014
Entrez Id: 283
Gene Symbol: ANG
ANG
0.010 AlteredExpression disease BEFREE However, pterygium body V had a weak association with ANG expression. 23989187 2013
Entrez Id: 51129
Gene Symbol: ANGPTL4
ANGPTL4
0.010 Biomarker disease BEFREE Our results support the development of therapies targeting both ANGPTL4 and VEGF for the treatment of patients with pterygia. 28873177 2017
Entrez Id: 328
Gene Symbol: APEX1
APEX1
0.010 GeneticVariation disease BEFREE XRCC1, but not APE1 and hOGG1 gene polymorphisms is a risk factor for pterygium. 20577654 2010
Entrez Id: 546
Gene Symbol: ATRX
ATRX
0.010 AlteredExpression disease BEFREE Lower expression of the RAD54 gene in pterygium tissue comparing to conjunctiva from the eyes with pterygium was found. 21077755 2011
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.020 AlteredExpression disease BEFREE 15 specimens of pterygia from 15 eyes were examined, together with normal conjunctival tissue from the same eyes for the pattern of gene expression of genes associated with the induction or repression of apoptosis (p53, bcl-2, and bax). 10655200 2000
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.020 Biomarker disease BEFREE In the molecules involved in apoptosis, the results showed that the positive rate of Bcl-2 and mP53 significantly increased in the pterygium samples. 21738398 2011
Entrez Id: 599
Gene Symbol: BCL2L2
BCL2L2
0.200 Biomarker disease RGD Regulation of Apoptosis by miR-122 in Pterygium via Targeting Bcl-w. 27415790 2016
Entrez Id: 23299
Gene Symbol: BICD2
BICD2
0.310 GeneticVariation disease BEFREE Another stillborn infant with pterygia and arthrogryposis had a heterozygous de novo likely pathogenic variant in BICD2. 29274205 2018
Entrez Id: 23299
Gene Symbol: BICD2
BICD2
0.310 Biomarker disease GENOMICS_ENGLAND In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis. 30054298 2018
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.010 AlteredExpression disease BEFREE However, no difference was found between the pterygium and normal conjunctiva samples in the expression of Bax and caspase-3. 21738398 2011
Entrez Id: 1490
Gene Symbol: CCN2
CCN2
0.010 Biomarker disease BEFREE We report on the presence of CTGF in pterygium and its simultaneous presence with vascular endothelial growth factor (VEGF). 12605268 2003
Entrez Id: 947
Gene Symbol: CD34
CD34
0.030 Biomarker disease BEFREE This result was confirmed with double immunofluorescence labeling, revealing that in pterygium stromal TCs always showed a PDGFRα+/nestin+ and PDGFRα+/CD34+ immunophenotype. 30713424 2018
Entrez Id: 947
Gene Symbol: CD34
CD34
0.030 AlteredExpression disease BEFREE Most significantly, western blotting confirmed that two candidate proteins matrix metalloproteinase 10 (MMP-10) and CD34 were significantly upregulated in pterygia, suggesting that they have potential roles in the pathogenesis of pterygia. 28261971 2017
Entrez Id: 947
Gene Symbol: CD34
CD34
0.030 Biomarker disease BEFREE On the basis of biological processes in gene ontology, the identified proteins were mainly involved in cellular process, metabolic process, developmental process, location, cellular component organization, Among these proteins, matrix Metalloproteinase 10 (MMP-10) and CD34 may have potential roles in the pathogenesis of pterygia. 28087900 2017
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.010 PosttranslationalModification disease BEFREE However, no studies have examined the reason for E-cadherin protein inactivation in pterygia. 20596253 2010
Entrez Id: 1027
Gene Symbol: CDKN1B
CDKN1B
0.010 Biomarker disease BEFREE Pterygium cell line (PECs) cell models were used to confirm the effect of β-catenin, miR-221, and p27Kip1 gene in the proliferation of pterygium cells. 25053875 2014
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.020 PosttranslationalModification disease BEFREE The purpose of this study was to investigate hypermethylation of the p16 promoter in pterygia and the relationship between this hypermethylation and the expression of p16 and DNA methyltransferase 3b (DNMT3b) proteins. 17149367 2006
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.020 AlteredExpression disease BEFREE Telomerase reverse transcriptase was expressed, and p53 and p16 levels were reduced in immortalized pterygium fibroblast cells. 24012806 2013
Entrez Id: 105375847
Gene Symbol: CERNA3
CERNA3
0.010 GeneticVariation disease BEFREE The point missense mutations at codon 61 were glutamine to arginine (Glu61Arg CAA>CGA) in four cases and glutamine to leucine (Glu61Leu CAA>CTA) in three cases.ConclusionThe significantly higher frequency of codon 61 mutation of the ras oncogene in primary and bilateral pterygium specimens compared with normal conjunctiva supports the tumoral origin of pterygium, and thus set the stage for research into a targeted therapy for pterygium with better outcomes than surgical excision. 27834959 2017